Leiutis marks milestone with CDSCO approval for Synthetic Cannabidiol Oral Solution for mild to moderate anxiety disorders Read more
Biocon and Equillium expand exclusive licensing agreement for Itolizumab to include Australia and New Zealand Read more
Routine pneumococcal vaccination rates remain high in children, but subpar in elderly: GlobalData Report Read more